TSC2 and tuberous sclerosis: In summary, 106 out of 116 individuals with a clinical diagnosis of TSC had pathogenic DNA alterations in TSC1 or TSC2 identified by DNA sequencing or MLPA, confirmed by functional assessment or qPCR, if indicated.